<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6045569</article-id><article-id pub-id-type="publisher-id">28880</article-id><article-id pub-id-type="doi">10.1038/s41598-018-28880-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Sustainable Syntheses of (&#8722;)-Jerantinines A &amp; E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Smedley</surname><given-names>Christopher J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stanley</surname><given-names>Paul A.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Qazzaz</surname><given-names>Mohannad E.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Prota</surname><given-names>Andrea E.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Olieric</surname><given-names>Natacha</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6220-1236</contrib-id><name><surname>Collins</surname><given-names>Hilary</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Eastman</surname><given-names>Harry</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Barrow</surname><given-names>Andrew S.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lim</surname><given-names>Kuan-Hon</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kam</surname><given-names>Toh-Seok</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0498-1910</contrib-id><name><surname>Smith</surname><given-names>Brian J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7366-6861</contrib-id><name><surname>Duivenvoorden</surname><given-names>Hendrika M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Parker</surname><given-names>Belinda S.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bradshaw</surname><given-names>Tracey D.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6157-3687</contrib-id><name><surname>Steinmetz</surname><given-names>Michel O.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Moses</surname><given-names>John E.</given-names></name><address><email>J.Moses@latrobe.edu.au</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2342 0938</institution-id><institution-id institution-id-type="GRID">grid.1018.8</institution-id><institution>La Trobe Institute for Molecular Science, </institution><institution>La Trobe University, </institution></institution-wrap>Melbourne, VIC 3086 Australia </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8868</institution-id><institution-id institution-id-type="GRID">grid.4563.4</institution-id><institution>School of Pharmacy, </institution><institution>University of Nottingham, University Park, </institution></institution-wrap>Nottingham, NG7 2RD UK </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1090 7501</institution-id><institution-id institution-id-type="GRID">grid.5991.4</institution-id><institution>Laboratory of Biomolecular Research, Division of Biology and Chemistry, </institution><institution>Paul Scherrer Institute, </institution></institution-wrap>CH-5232 Villigen PSI, Switzerland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0642</institution-id><institution-id institution-id-type="GRID">grid.6612.3</institution-id><institution>University of Basel, Biozentrum, </institution></institution-wrap>CH-4056 Basel, Switzerland </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.440435.2</institution-id><institution>School of Pharmacy, </institution><institution>University of Nottingham Malaysia Campus, Jalan Broga, </institution></institution-wrap>43500 Semenyih, Selangor Malaysia </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2308 5949</institution-id><institution-id institution-id-type="GRID">grid.10347.31</institution-id><institution>Department of Chemistry, </institution><institution>Faculty of Science, University of Malaya, </institution></institution-wrap>50603 Kuala Lumpur, Malaysia </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>8</volume><elocation-id>10617</elocation-id><history><date date-type="received"><day>2</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>29</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>&#169; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The jerantinine family of <italic>Aspidosperma</italic> indole alkaloids from <italic>Tabernaemontana corymbosa</italic> are potent microtubule-targeting agents with broad spectrum anticancer activity. The natural supply of these precious metabolites has been significantly disrupted due to the inclusion of <italic>T. corymbosa</italic> on the endangered list of threatened species by the International Union for Conservation of Nature. This report describes the asymmetric syntheses of (&#8722;)-jerantinines A and E from sustainably sourced (&#8722;)-tabersonine, using a straight-forward and robust biomimetic approach. Biological investigations of synthetic (&#8722;)-jerantinine A, along with molecular modelling and X-ray crystallography studies of the tubulin&#8212;(&#8722;)-jerantinine B acetate complex, advocate an anticancer mode of action of the jerantinines operating <italic>via</italic> microtubule disruption resulting from binding at the colchicine site. This work lays the foundation for accessing useful quantities of enantiomerically pure jerantinine alkaloids for future development.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Natural products have made an enormous contribution in the treatment of cancer, with over half of the current anticancer drugs in clinical use being natural products or natural product derivatives<sup><xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR3">3</xref></sup>. Sometimes, however, there are disadvantages when using natural products as lead structures in drug discovery. Typically isolated from source in only minute quantities, the challenge of accessing useful quantities of these precious metabolites can present significant bottlenecks for development. This is particularly conspicuous when the natural supply has been exhausted and, in such instances, synthesis remains the only viable option. However, secondary metabolites are often incredibly challenging targets with unprecedented molecular connectivity and structural complexity<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, and even when successful, total synthesis does not always result in adequate quantities of material for developmental studies<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>.</p><p id="Par3">The tubulin binding<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>
<italic>Vinca</italic> indole alkaloids, including vincristine and vinblastine are classic examples of structurally complex natural products that are among the foremost drugs used in cancer chemotherapy<sup><xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. However, owing to their structural complexity, the <italic>de novo</italic> synthesis of these important drugs remains a significant challenge<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>, and clinical supplies of vincristine and vinblastine primarily rely upon natural sources<sup><xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR15">15</xref></sup>. Another major limitation to the continued use of the <italic>Vinca</italic> alkaloids is the emergence of drug resistance, derived primarily from the overexpression of phosphoglycoprotein (Pgp) efflux pump, that is responsible for transporting many of the major drugs out of the cell<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. Accordingly, the discovery and synthesis of bioactive alkaloids that overcome these resistance mechanisms is of high priority for anticancer drug development.</p><p id="Par4">In 2008, several new <italic>Aspidosperma</italic> indole alkaloids, (&#8722;)-jerantinines A&#8211;G, were isolated by Kam and co-workers, from a leaf extract of the Malayan <italic>Tabernaemontana corymbosa</italic> Roxb. ex Wall<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. The jerantinines displayed pronounced <italic>in vitro</italic> cytotoxicity toward drug-sensitive as well as vincristine-resistant (VJ300) KB cells (IC<sub>50</sub>&#8201;&lt;&#8201;1&#8201;&#956;g/mL)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, which is uncommon among simple <italic>Aspidosperma</italic> alkaloids. Studies have shown that both (&#8722;)-jerantinines A (<bold>1</bold>) and E (<bold>3</bold>) are microtubule-destabilising agents (MDAs)<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>, whereas <bold>1</bold> also induces tumour-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>.</p><p id="Par5">The antiproliferative and pro-apoptotic activities of the jerantinines <italic>via</italic> mechanisms involving perturbation of validated antitumor targets warrant further investigation as potential chemotherapeutic agents. However, the inclusion of <italic>T. corymbosa</italic> on the endangered list of threatened species by the International Union for Conservation of Nature (IUCN)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, limits the source of these natural compounds, and a practical synthetic route is urgently required.</p><p id="Par6">To date, there have been only three reported synthetic studies towards the jerantinine alkaloids. Waser <italic>et al</italic>. reported the first synthesis of jerantinine E (<bold>3</bold>), which involved a key homo-Nazarov cyclisation of an aminocyclopropane to access four of the five rings, leading to racemic (&#177;)-(<bold>3</bold>) in 17-steps and 16% overall yield<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. In 2017, Magauer and co-workers described a convergent synthesis to the ABC ring system of jerantinine E (<bold>3</bold>) that employed a <italic>&#946;</italic>-C&#8211;H enone bromination followed by a palladium-catalysed amination and oxidative indole formation to yield a tricyclic core<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>.</p><p id="Par7">Very recently, Jiang and co-workers completed the first total syntheses of (&#8722;)-jerantinines A (<bold>1</bold>), C (<bold>2</bold>) and E (<bold>3</bold>) in 12&#8211;13 steps<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. The key steps of this route included a stereoselective intramolecular inverse-electron demand [4&#8201;+&#8201;2] cycloaddition, an &#945;,&#946;-unsaturated ketone indolisation and a Pd/C-catalysed cascade reaction.</p><p id="Par8">Continuing our work on the biomimetic synthesis of natural products<sup><xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref></sup>, we report here the asymmetric and sustainable semi-syntheses of both (&#8722;)-jerantinine A (<bold>1</bold>) and (&#8722;)-jerantinine E (<bold>3</bold>), and provide supporting biological and structural data to further advocate a mechanism of action of the jerantinines <italic>via</italic> microtubule disruption.</p><p id="Par9">The indole alkaloid (&#8722;)-tabersonine (<bold>4</bold>) was proposed as a plausible precursor to the jerantinines &#8212; diverging from the vindoline biosynthetic pathway<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>, a selective C-15<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> A-ring oxidation of 16-methoxytabersonine (<bold>5</bold>) would give <bold>1</bold> directly<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR32">32</xref></sup>. Alternatively, the C16 <italic>ortho</italic>-hydroxylation and subsequent methylation of the metabolite melodinine P (<bold>6</bold>) (from <italic>Melodinus suaveolens</italic>) would directly give <bold>1</bold> (Figs&#160;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>)<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.<fig id="Fig1"><label>Figure 1</label><caption><p>A selection of <italic>Vinca</italic> and <italic>Aspidosperma</italic> alkaloids.</p></caption><graphic xlink:href="41598_2018_28880_Fig1_HTML" id="d29e630"/></fig><fig id="Fig2"><label>Figure 2</label><caption><p>(<bold>A</bold>) Speculative biosynthetic pathway of jerantinine A and related vinca alkaloids (<bold>1</bold>) (<bold>B</bold>) Sustainable biomimetic semi-synthesis of (&#8722;)-jerantinine A (<bold>1</bold>) and (&#8722;)-jerantinine E (<bold>3</bold>), beginning from the proposed biogenetic precursor, (&#8722;)-tabersonine (<bold>4</bold>).</p></caption><graphic xlink:href="41598_2018_28880_Fig2_HTML" id="d29e658"/></fig></p><p id="Par10">Thus, inspired by Nature&#8217;s efficiency in creating vast numbers of complex molecules from a single precursor, and the opportunity to exploit a readily available and sustainable natural feedstock, we elected to explore tabersonine (<bold>4</bold>) as a platform for synthetic elaboration into (&#8722;)-jerantinine A (<bold>1</bold>)<sup><xref ref-type="bibr" rid="CR34">34</xref>&#8211;<xref ref-type="bibr" rid="CR36">36</xref></sup>.</p><p id="Par11">Studies commenced with the multi-gram scale extraction of <bold>4</bold> from the ground seeds of <italic>Voacanga Africana</italic><sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>, giving consistent yields of up to 1.4% by mass recovery. The reaction of <bold>4</bold> with <italic>N-</italic>iodosuccinimide in TFA at room temperature gave exclusively the 15-iodotabersonine (<bold>11</bold>) in 94% yield<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. We anticipated that a Miyaura borylation followed by oxidation would conveniently install the required C-15 hydroxyl<sup><xref ref-type="bibr" rid="CR40">40</xref>&#8211;<xref ref-type="bibr" rid="CR42">42</xref></sup>, but upon experimentation we found that protection of the indoline nitrogen was first required to prevent unwanted side reactions. Gratifyingly, the <italic>N</italic>-Boc-iodotabersonine <bold>12</bold> reacted smoothly to give the boronate ester <bold>13</bold>, which upon exposure to NMO yielded hydroxytabersonine <bold>14</bold> in 93% yield over 2 steps<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. The next challenge was to install the critical C-16 hydroxyl, and we elected here to investigate a classical <italic>ortho</italic>-formylation followed by Dakin oxidation sequence; given the sterically more encumbered C-14 ring position, we were confident that this could be achieved with good regiochemical control. This proved to be robust and convenient; thus, upon treatment of the Boc-protected <bold>14</bold> with paraformaldehyde in the presence of MgCl<sub>2</sub> and Et<sub>3</sub>N, the C-16-aldehyde <bold>15</bold> was isolated in 98% yield<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. Exposing <bold>15</bold> to a solution of hydrogen peroxide with a trace amount of SeO<sub>2</sub><sup><xref ref-type="bibr" rid="CR44">44</xref></sup> in <italic>tert</italic>-butanol gave a complex mixture, and therefore an operationally convenient one-pot procedure was developed; aldehyde <bold>15</bold> was fully oxidised to the quinone, back-reduced with sodium dithionite and the catechol trapped by methylation to give the dimethoxy derivative <bold>16</bold> in 53% yield. Finally, sequential <italic>N</italic>-Boc deprotection and selective demethylation under Waser&#8217;s conditions<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, furnished (&#8722;)-jerantinine A (<bold>1</bold>) in 72% yield, and 29% overall yield from (&#8722;)-tabersonine (<bold>4</bold>). Synthetic jerantinine A (<bold>1</bold>) was shown to be identical to natural jerantinine A through comparison of their <sup>1</sup>H and <sup>13</sup>C NMR spectroscopic data (Table&#160;<xref rid="MOESM1" ref-type="media">S1</xref>). The conversion of <bold>1</bold> into (&#8722;)-jerantinine E (<bold>3</bold>) was accomplished upon selective reduction of the &#916;<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup> double bond through H<sub>2</sub> over PtO<sub>2</sub> in 77% (23% overall yield, Scheme 1).</p><p id="Par12">With significant amounts of synthetic <bold>1</bold> and synthetic intermediates <italic>en route</italic> to <bold>1</bold>, we next explored the cytotoxicity of these molecules (See SI, Table&#160;<xref rid="MOESM1" ref-type="media">S-2</xref>). The human-derived MCF-7 breast and HCT116 colorectal carcinoma cell lines were chosen, since they are representative of two of the most prevalent types of cancer. <italic>In vitro</italic> antitumour activity of synthetic <bold>1</bold> was indistinguishable from the natural compound; for example, in MTT tests GI<sub>50</sub> values &lt;1&#8201;&#956;M against colorectal and mammary human-derived carcinoma cell lines were observed for both samples of <bold>1</bold> (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>) - dose-response profiles are shown in supplementary data (Fig.&#160;<xref rid="MOESM1" ref-type="media">S-1</xref>). Furthermore, both the synthetic and natural <bold>1</bold> dramatically and significantly inhibited colony formation of HCT116 cells when treated at the GI<sub>50</sub> concentration (Fig.&#160;<xref rid="Fig3" ref-type="fig">3A</xref>). Cell cycle analyses demonstrated that at 0.8&#8201;&#181;M, both natural and synthetic <bold>1</bold> profoundly perturbed the cell cycle, causing stark arrest at G2/M phase (See SI, Fig.&#160;<xref rid="MOESM1" ref-type="media">S-1</xref>). Collectively, these data advocate that mitotic microtubule assembly has been disrupted. Indeed, at 1&#8201;&#956;M naturally sourced and synthetic (&#8722;)-<bold>1</bold> both abolished tubulin polymerisation <italic>in vitro</italic> as profoundly as the 5&#8201;&#956;M nocodazole control (Fig.&#160;<xref rid="Fig3" ref-type="fig">3B</xref>). MCF-7 cells were treated for 24&#8201;h with 0.8&#8201;&#181;M <bold>1</bold>, stained (DRAQ5 and monoclonal anti &#945;-tubulin Ab) and the images viewed by confocal microscopy. As shown in Fig.&#160;<xref rid="Fig3" ref-type="fig">3C</xref>, many characteristic features of the action of a microtubule disrupting agent (MDA) were observed, including formation of multipolar spindles, misaligned chromosomes, multinucleation (aneuploidy) and nuclear fragmentation<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>GI<sub>50</sub> values of natural product and synthetic jerantinine A (<bold>1</bold>) and colchicine against human-derived colorectal (HCT116) and mammary (MCF-7) carcinoma cell lines.</p></caption><table-wrap-foot><p>Data calculated from n &#8805; 3 trials; n&#8201;=&#8201;8 per concentration point per trial.</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Figure 3</label><caption><p>(<bold>A</bold>) Effect of natural and synthetic <bold>1</bold> on HCT-116 colony formation at GI<sub>50</sub> (see Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Mean survival fraction (%) of treated cells as a percentage of the control population for HCT-116. Cells were seeded (400 per well) and allowed 24&#8201;h to attach before being challenged with jerantinine A (24&#8201;h). The number of colonies forming after 8 d incubation was determined. Mean (&#177;S.E.M.) values are given. Data were generated from &#8805;3 separate trials; n&#8201;=&#8201;2 per trial; (<bold>B</bold>) <italic>In vitro</italic> tubulin polymerisation in the presence of vehicle control, paclitaxel (5&#8201;&#956;M; positive control), nocodazole (5&#8201;&#956;M; negative control) or <bold>1</bold> (1&#8201;&#181;M); (<bold>C</bold>) Immunofluorescent and DRAQ5 staining of x) untreated MCF-7 cells and y-z) cells exposed to synthetic <bold>1</bold> (1&#8201;&#215;&#8201;GI<sub>50</sub>&#8201;=&#8201;0.81&#8201;&#956;M; 24&#8201;h), showing the effect on microtubules (green) and the cellular DNA (purple). Synthetic (&#8722;)-jerantinine A (<bold>1</bold>) caused multinucleation (i), nuclear fragmentation (ii) and formation of multipolar spindles (iii).</p></caption><graphic xlink:href="41598_2018_28880_Fig3_HTML" id="d29e992"/></fig></p><p id="Par13">Following these results, we tested the impact of jerantinine A (<bold>1</bold>) and colchicine on breast cancer cell growth in 3D culture (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>). After 96&#8201;h of exposure to either agent, the cell density of both cell lines (measured as area) was decreased compared to control (Fig.&#160;<xref rid="Fig4" ref-type="fig">4B and C</xref>). Jerantinine A (<bold>1</bold>) decreased cell density of the MDA-MB-231 to a greater extent than colchicine following 96&#8201;h of exposure (Fig.&#160;<xref rid="Fig4" ref-type="fig">4B</xref>). The invasive nature of the MDA-MB-231 triple negative breast cancer cell line was also decreased by treatment with jerantinine A (<bold>1</bold>) or colchicine.<fig id="Fig4"><label>Figure 4</label><caption><p>(<bold>A</bold>) MDA-MB-231 and MCF-7 breast cancer cells grown in 3D culture with vehicle (DMSO), jerantinine A (<bold>1</bold>) (5.36&#8201;&#181;M or 1.22&#8201;&#181;M&#8218; respectively) or colchicine (10&#8201;&#181;M or 14.5&#8201;&#181;M&#8218; respectively). Images from 96&#8201;h post agent exposure. Scale bar represents 200&#8201;&#181;m. (<bold>B</bold>) Quantification of the area of the MDA-MB-231 3D colonies over a 96&#8201;h period post agent addition. Mean (&#177;S.E.M.) values are given. (<bold>C</bold>) Quantification of the area of the MCF-7 3D colonies over a 96&#8201;h period post agent addition. Mean (&#177;S.E.M.) values are given. Data were generated from &#8805;2 separate trials; n&#8201;=&#8201;2 per trial; *p&#8201;&lt;&#8201;0.05, **p&#8201;&lt;&#8201;0.01, ****p&#8201;&lt;&#8201;0.0001.</p></caption><graphic xlink:href="41598_2018_28880_Fig4_HTML" id="d29e1034"/></fig></p><p id="Par14">Soaking experiments with a selection of the jerantinine metabolites and derivatives into a crystal formed by a protein complex composed of two &#945;&#946;-tubulin heterodimers, the stathmin-like protein RB3 and tubulin tyrosine ligase (T<sub>2</sub>R-TTL)<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>, yielded the tubulin-jerantinine B acetate (<bold>9</bold>) structure at 2.4&#8201;&#197; resolution (Fig.&#160;<xref rid="Fig5" ref-type="fig">5A</xref>; Table&#160;<xref rid="MOESM1" ref-type="media">S-3</xref>). The overall structure of the two tubulin dimers in the T<sub>2</sub>R-TTL-<bold>9</bold> complex superimposed well with the one obtained in the absence of a ligand<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> (Fig.&#160;<xref rid="MOESM1" ref-type="media">S-3A</xref>; rmsd<sub>overall</sub> of 0.48&#8201;&#197; over 1814 C&#945;-atoms; rmsd<sub>chain B</sub> 0.24&#8201;&#197; over 351&#8201;C&#945;-atoms). This result suggests that binding of the ligand does not affect the gross conformation of tubulin. Thus, the complex structure reveals that <bold>9</bold> binds to the colchicine site of tubulin that is shaped by residues of strands &#946;S8 and &#946;S9, loop &#946;T7, and helices &#946;H7 and &#946;H8 of &#946;-tubulin, and loop &#945;T5 of &#945;-tubulin (Fig.&#160;<xref rid="Fig5" ref-type="fig">5B</xref>).<fig id="Fig5"><label>Figure 5</label><caption><p>Crystal structure of the tubulin-jerantinine B acetate (<bold>9</bold>) complex. (<bold>A</bold>) Overall view of the T<sub>2</sub>R-TTL-jerantinine B acetate complex structure. The &#945;- and &#946;-tubulin chains are in dark and light grey ribbon representation, respectively. The tubulin-bound <bold>9</bold> and GTP molecules are represented as green and orange spheres, respectively; (<bold>B</bold>) Close-up view of the interactions observed between <bold>9</bold> (green) and tubulin (grey). Interacting residues of tubulin are shown in stick representation and are labelled. Oxygen and nitrogen atoms are coloured red and blue, respectively; carbon atoms are in green <bold>9</bold> or grey (tubulin). Secondary structural elements of tubulin are labelled in blue. For simplicity, only &#945;-tubulin residues are indicated with an &#945;; (<bold>C</bold>) Superimposition of the tubulin-<bold>9</bold> (green/grey) and the tubulin-colchicine (pink; PDB ID 4O2B; rmsd of 0.204&#8201;&#197; over 351&#8201;C&#945;-atoms) complex structures. The structures were superimposed onto their &#946;1-tubulin chains; (<bold>D</bold>) Molecular docking of (&#8722;)-jerantinine A (<bold>1</bold>) in the colchicine binding pocket of tubulin; this pocket is formed by residues in the &#945;T5-loop on &#945;-tubulin, and &#946;H7, &#946;H8, &#946;S8, &#946;S9 and the &#946;T7-loop on &#946;-tubulin. For additional experimental details see the Supporting Information.</p></caption><graphic xlink:href="41598_2018_28880_Fig5_HTML" id="d29e1125"/></fig></p><p id="Par15">Superimposition of the tubulin-<bold>9</bold> structure onto the tubulin-colchicine structure (rmsd of 0.204&#8201;&#197; over 351&#8201;C&#945;-atoms, chain B)<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> revealed a perfect overlap of the jerantinine A-ring of <bold>9</bold> with the C-ring of colchicine and two major conformational changes in the binding site of <bold>9</bold> (Fig.&#160;<xref rid="Fig5" ref-type="fig">5C</xref>). In the jerantinine structure, Thr179 on the &#945;T5 loop is in the flipped-in conformation and forms a hydrophobic contact to Leu248 on the &#946;T7 loop. In the colchicine structure Thr179 is in the flipped-out conformation to avoid clashes with the acetamide moiety. Moreover, jerantinine-binding induces a rearrangement of Leu248 on the &#946;T7 loop to prevent clashes with the epoxide moiety on the D-ring of <bold>9</bold> (Fig.&#160;<xref rid="Fig4" ref-type="fig">4C</xref>), and of Ala250 and Leu255 to fill the space that is otherwise occupied by the A-ring of colchicine.</p><p id="Par16">Tubulin dimers in microtubules assume a &#8220;straight&#8221; structure; in contrast, free tubulin is characterised by a &#8220;curved&#8221; conformation<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>. The jerantinine B acetate (<bold>9</bold>) prevents the curved-to-straight structural transition by sterically hindering the &#946;T7 loop adopting its conformation characteristic of the straight tubulin state (Fig.&#160;<xref rid="MOESM1" ref-type="media">S-3B</xref>), a mechanism that is similar to other colchicine-site ligands<sup><xref ref-type="bibr" rid="CR49">49</xref>,<xref ref-type="bibr" rid="CR51">51</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref></sup>.</p><p id="Par17">Subsequent molecular docking studies revealed a distinct preference of jerantinines A (<bold>1</bold>) and E (<bold>3</bold>) for the colchicine pocket (Fig.&#160;<xref rid="Fig5" ref-type="fig">5D</xref>, Table&#160;<xref rid="MOESM1" ref-type="media">S-4</xref>)<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Binding energies to either the vinblastine or taxol sites were approximately 10 and 15&#8201;kJ&#8201;mol<sup>&#8722;1</sup>, respectively, lower than the colchicine site. Jerantinine B acetate (<bold>9</bold>) was calculated as the tightest binding ligand of the family, and was predicted to bind ~5&#8201;kJ&#8201;mol<sup>&#8722;1</sup> more tightly than colchicine. The structure of jerantinine B acetate closely matches the experimentally determined structure &#8211; rmsd of 0.68&#8201;&#197;. The predicted binding orientation of all the jerantinine derivatives, in the colchicine binding site, mirror that of jerantinine B acetate (<bold>9</bold>).</p><p id="Par18">In conclusion, we have described the asymmetric synthesis of the <italic>Aspidosperma</italic> alkaloid (&#8722;)-jerantinine A (<bold>1</bold>) in 9 steps and 29% overall yield, using a sustainable semi-synthetic approach. The selective reduction of (&#8722;)-<bold>1</bold> enabled the asymmetric synthesis of the corresponding (&#8722;)-jerantinine E (<bold>3</bold>). Our biomimetic approach began from the natural building block and plausible biosynthetic precursor (&#8722;)-tabersonine (<bold>4</bold>), that is readily available in large quantities from a sustainable plant-based source (<italic>Voacanga Africana</italic>). The synthesis enabled us to investigate the biological profile of (&#8722;)-jerantinine A (<bold>1</bold>), showing that activity of synthetic <bold>1</bold> is indistinguishable from that of the natural material against human derived breast (MCF-7) and colon carcinoma (HCT116) cell lines. A 3D culture assay showed that jerantinine A (<bold>1</bold>) decreased the cell density of two breast cancer cell lines, in particular demonstrating greater effectiveness than colchicine against MDA-MB-231 cells. Investigations into the mode of action suggested that <bold>1</bold> acts <italic>via</italic> disruption of the microtubule network, as indicated by its potent inhibitory activity displayed in tubulin polymerisation <italic>in vitro</italic>. This particular mode of action was further corroborated by solving of the crystal structure of the tubulin&#8212;jerantinine B acetate complex, revealing binding to the colchicine site and prevention of the &#8220;curved-to-straight&#8221; tubulin conformational transition that is necessary to enable microtubule formation.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec2"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2018_28880_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-018-28880-2.</p></fn><fn><p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank La Trobe University (C.J.S.) and the University of Nottingham (P.A.S. and H.E.) for providing PhD scholarships. We are indebted to Takashi Tomizaki and Meitian Wang for excellent technical assistance with the collection of X-ray data at beamline X06SA of the Swiss Light Source (Paul Scherrer Institut, Villigen PSI, Switzerland). J.E.M. thanks the ARC for a Future Fellowship (FT170100156). B.S.P. thanks the NHMRC for funding (BSP 1127754). M.E.Q. thanks the Higher Committee for Education Development in Iraq (HCED) for sponsorship. This work was further supported by a grant from the Swiss National Science Foundation (31003A_166608; to M.O.S.). Coordinates of the X-ray crystal structures have been deposited in the RCSB PDB (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link>) under accession number 6GF3 (tubulin-<bold>9</bold>).</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>J.E.M., M.O.S., T.D.B., B.J.S. and B.S.P. designed the research. C.J.S., P.A.S., H.E. and A.S.B. developed and performed the synthetic route. M.E.Q. performed the biological assays, H.C. conducted the confocal experiments, H.M.D. performed the 3D culture assays. A.E.P. and N.O. generated the X-ray crystal structure. K.-H.L. and T.-S.K. provided natural samples for biological testing and B.J.S. performed the computational modelling. J.E.M. prepared the manuscript with the assistance of the co-authors.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p id="Par19">The authors declare no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Cragg, G., Kingston, D. &amp; Newman, D. Anticancer agents from natural products, second ed. CRC Press, Boca Raton (2011).</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basmadjian</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cancer wars: natural products strike back</article-title><source>Front. Chem.</source><year>2014</year><volume>2</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.3389/fchem.2014.00020</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>GM</given-names></name><name><surname>Newman</surname><given-names>DJ</given-names></name></person-group><article-title>Natural Products: a Continuing Source of Novel</article-title><source>Biochim. Biophys. Acta.</source><year>2013</year><volume>1830</volume><fpage>3670</fpage><lpage>3695</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2013.02.008</pub-id><?supplied-pmid 23428572?><pub-id pub-id-type="pmid">23428572</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Sierra, M., de la Torre, M. &amp; Cossio, F. More Dead Ends and Detours: En Route to Successful Total Synthesis. Wiley-VCH, Weinheim (2013).</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Wilde</surname><given-names>NC</given-names></name><name><surname>Baran</surname><given-names>PS</given-names></name></person-group><article-title>Short, Enantioselective Total Synthesis of Highly Oxidized Taxanes</article-title><source>Angew. Chem. Int. Ed.</source><year>2016</year><volume>55</volume><fpage>8280</fpage><lpage>8284</lpage><pub-id pub-id-type="doi">10.1002/anie.201602235</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname><given-names>A</given-names></name><name><surname>Ishihara</surname><given-names>Y</given-names></name><name><surname>Baran</surname><given-names>PS</given-names></name></person-group><article-title>Scalable enantioselective total synthesis of taxanes</article-title><source>Nat. Chem.</source><year>2012</year><volume>4</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1038/nchem.1196</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">A number of natural products and natural product derivatives are known to bind to tubulin; for a recent review on the topic see: Dong, M., Liu, F., Zhou, H., Zhai, S. &amp; Yan, B. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site, <italic>M</italic><italic>olecules</italic>, 2<bold>1</bold>, 1375 (2016).</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>Q-Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>D-A</given-names></name></person-group><article-title>Microtubule-Binding Natural Products for Cancer Therapy</article-title><source>Planta Med.</source><year>2010</year><volume>76</volume><fpage>1037</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1250073</pub-id><?supplied-pmid 20577942?><pub-id pub-id-type="pmid">20577942</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gigant</surname><given-names>B</given-names></name><etal/></person-group><article-title>Structural basis for the regulation of tubulin by vinblastine</article-title><source>Nature</source><year>2005</year><volume>435</volume><fpage>519</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1038/nature03566</pub-id><?supplied-pmid 15917812?><pub-id pub-id-type="pmid">15917812</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sears</surname><given-names>JE</given-names></name><name><surname>Boger</surname><given-names>DL</given-names></name></person-group><article-title>Total Synthesis of Vinblastine, Related Natural Products, and Key Analogues and Development of Inspired Methodology Suitable for the Systematic Study of Their Structure-Function Properties</article-title><source>Acc. Chem. Res.</source><year>2015</year><volume>48</volume><fpage>653</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1021/ar500400w</pub-id><?supplied-pmid 25586069?><pub-id pub-id-type="pmid">25586069</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Total Synthesis of Vinblastine, Vincristine, Related Natural Products, and Key Structural Analogues</article-title><source>J. Am. Chem. Soc.</source><year>2009</year><volume>131</volume><fpage>4904</fpage><lpage>4916</lpage><pub-id pub-id-type="doi">10.1021/ja809842b</pub-id><?supplied-pmid 19292450?><pub-id pub-id-type="pmid">19292450</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Potier, P., Langlois, N., Langlois, Y. &amp; Gu&#233;ritte, F. Partial Synthesis of Vinblastine-type Alkaloids. <italic>J. Chem. Soc. Chem. Commun</italic>. 670&#8211;671 (1975).</mixed-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langlois</surname><given-names>N</given-names></name><name><surname>Gu&#233;ritte</surname><given-names>F</given-names></name><name><surname>Langlois</surname><given-names>Y</given-names></name><name><surname>Potier</surname><given-names>P</given-names></name></person-group><article-title>Application of a Modification of the Polonovski Reaction to the Synthesis of Vinblastine-Type Alkaloids</article-title><source>J. Am. Chem. Soc.</source><year>1976</year><volume>98</volume><fpage>7017</fpage><lpage>7024</lpage><pub-id pub-id-type="doi">10.1021/ja00438a046</pub-id><?supplied-pmid 965661?><pub-id pub-id-type="pmid">965661</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutney</surname><given-names>JP</given-names></name><name><surname>Ratcliffe</surname><given-names>AH</given-names></name><name><surname>Treasurywala</surname><given-names>AM</given-names></name><name><surname>Wunderly</surname><given-names>S</given-names></name></person-group><article-title>Studies on the synthesis of bisindole alkaloids II. The synthesis of 3&#8242;,4&#8242;-dehydrovinblastine, 4&#8242;-deoxovinblastine and related analogues</article-title><source>The biogenetic approach. Heterocycles</source><year>1975</year><volume>3</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.3987/R-1975-08-0639</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutney</surname><given-names>JP</given-names></name><name><surname>Hibino</surname><given-names>T</given-names></name><name><surname>Jahngen</surname><given-names>E</given-names></name><name><surname>Okutani</surname><given-names>T</given-names></name></person-group><article-title>Total Synthesis of Indole and Dihydroindole Alkaloids</article-title><source>Helv. Chim. Acta.</source><year>1976</year><volume>59</volume><fpage>2858</fpage><lpage>2882</lpage><pub-id pub-id-type="doi">10.1002/hlca.19760590824</pub-id><?supplied-pmid 1017976?><pub-id pub-id-type="pmid">1017976</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumontet</surname><given-names>C</given-names></name><name><surname>Sikic</surname><given-names>BI</given-names></name></person-group><article-title>Mechanisms of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death</article-title><source>J. Clin. Oncol.</source><year>1999</year><volume>17</volume><fpage>1061</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1200/JCO.1999.17.3.1061</pub-id><?supplied-pmid 10071301?><pub-id pub-id-type="pmid">10071301</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname><given-names>M</given-names></name><etal/></person-group><article-title>Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>31269</fpage><lpage>31275</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.52.31269</pub-id><?supplied-pmid 8537394?><pub-id pub-id-type="pmid">8537394</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>K-H</given-names></name><name><surname>Hiraku</surname><given-names>O</given-names></name><name><surname>Komiyama</surname><given-names>K</given-names></name><name><surname>Kam</surname><given-names>T-S</given-names></name></person-group><article-title>Jerantinines A-G, cytotoxic <italic>Aspidosperma</italic> alkaloids from <italic>Tabernaemontana corymbosa</italic></article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>1591</fpage><lpage>1594</lpage><pub-id pub-id-type="doi">10.1021/np800435c</pub-id><?supplied-pmid 18778099?><pub-id pub-id-type="pmid">18778099</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raja</surname><given-names>VJ</given-names></name><name><surname>Lim</surname><given-names>KH</given-names></name><name><surname>Leong</surname><given-names>CO</given-names></name><name><surname>Kam</surname><given-names>TS</given-names></name><name><surname>Bradshaw</surname><given-names>TD</given-names></name></person-group><article-title>Novel antitumour indole alkaloid, Jerantinine A, evokes potent G2/M cell cycle arrest targeting microtubules</article-title><source>Invest. New Drugs.</source><year>2014</year><volume>32</volume><fpage>838</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1007/s10637-014-0126-1</pub-id><?supplied-pmid 24927857?><pub-id pub-id-type="pmid">24927857</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>R</given-names></name><etal/></person-group><article-title>Total Synthesis and Biological Evaluation of Jerantinine E</article-title><source>Angew. Chem. Int. Ed.</source><year>2013</year><volume>52</volume><fpage>13373</fpage><lpage>13376</lpage><pub-id pub-id-type="doi">10.1002/anie.201305533</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>FF</given-names></name></person-group><article-title>-L. <italic>et al</italic>. Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41598-016-0028-x</pub-id><pub-id pub-id-type="pmid">28127051</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Iucnredlist.org. <italic>T</italic><italic>abernaemontana corymbosa</italic>, <ext-link ext-link-type="uri" xlink:href="http://www.iucnredlist.org/details/34504/0">http://www.iucnredlist.org/details/34504/0</ext-link> (2017).</mixed-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>T</given-names></name><name><surname>Preuhs</surname><given-names>TA</given-names></name><name><surname>Gerlinger</surname><given-names>CKG</given-names></name><name><surname>Magauer</surname><given-names>T</given-names></name></person-group><article-title>Development of a <italic>&#946;</italic>-C-H Bromination Approach toward the Synthesis of Jerantinine E</article-title><source>J. Org. Chem.</source><year>2017</year><volume>52</volume><fpage>7410</fpage><lpage>7419</lpage><pub-id pub-id-type="doi">10.1021/acs.joc.7b01095</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name></person-group><article-title>Asymmetric Total Syntheses of (&#8722;)-Jerantinines A, C, and E, (&#8722;)&#8722;16-Methoxytabersonine, (&#8722;)-Vindoline, and (+)-Vinblastine</article-title><source>Org. Lett.</source><year>2018</year><volume>20</volume><fpage>292</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.7b03694</pub-id><?supplied-pmid 29272137?><pub-id pub-id-type="pmid">29272137</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>JC</given-names></name><name><surname>Davies</surname><given-names>ES</given-names></name><name><surname>Walsh</surname><given-names>DA</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Moses</surname><given-names>JE</given-names></name></person-group><article-title>Formal synthesis of kingianin A based upon a novel electrochemically-induced radical cation Diels&#8211;Alder reaction</article-title><source>Chem. Commun.</source><year>2014</year><volume>50</volume><fpage>12523</fpage><lpage>12525</lpage><pub-id pub-id-type="doi">10.1039/C4CC05906A</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Ritson</surname><given-names>DJ</given-names></name><name><surname>Burnley</surname><given-names>J</given-names></name><name><surname>Moses</surname><given-names>JE</given-names></name></person-group><article-title>A synthetic approach to kingianin A based on biosynthetic speculation</article-title><source>Chem. Commun.</source><year>2011</year><volume>47</volume><fpage>10605</fpage><pub-id pub-id-type="doi">10.1039/c1cc13949e</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name><etal/></person-group><article-title>Biomimetic Synthesis and Structural Reassignment of the Tridachiahydropyrones</article-title><source>J. Am. Chem. Soc.</source><year>2009</year><volume>131</volume><fpage>5966</fpage><lpage>5972</lpage><pub-id pub-id-type="doi">10.1021/ja900369z</pub-id><?supplied-pmid 19341238?><pub-id pub-id-type="pmid">19341238</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLuca</surname><given-names>V</given-names></name><etal/></person-group><article-title>Biosynthesis of Indole Alkaloids: Developmental Regulation of the Biosynthetic Pathway from Tabersonine to Vindoline in <italic>Catharanthus roseus</italic></article-title><source>J. Plant Physiol.</source><year>1986</year><volume>125</volume><fpage>147</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/S0176-1617(86)80252-8</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast</article-title><source>Proc. Natl. Acad. Sci.</source><year>2015</year><volume>112</volume><fpage>6224</fpage><lpage>6229</lpage><pub-id pub-id-type="doi">10.1073/pnas.1501821112</pub-id><?supplied-pmid 25918424?><pub-id pub-id-type="pmid">25918424</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname></name><etal/></person-group><article-title>[ref 18] uses the biogentic numbering system. The numbering system used throughout this paper is one proposed by: Le Men, J. &amp; Taylor, W. I. A uniform numbering system for indole alkaloids</article-title><source>Experientia.</source><year>1965</year><volume>21</volume><fpage>508</fpage><lpage>510</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besseau</surname><given-names>S</given-names></name><etal/></person-group><article-title>A Pair of Tabersonine 16-Hydroxylases Initiates the Synthesis of Vindoline in an Organ-Dependent Manner in Catharanthus roseus</article-title><source>Plant Physiol.</source><year>2013</year><volume>163</volume><fpage>1792</fpage><lpage>1803</lpage><pub-id pub-id-type="doi">10.1104/pp.113.222828</pub-id><?supplied-pmid 24108213?><pub-id pub-id-type="pmid">24108213</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>J</given-names></name><name><surname>Luca</surname><given-names>V</given-names></name></person-group><article-title>De. Localization of tabersonine 16-hydroxylase and 16-OH tabersonine-16-O- methyltransferase to leaf epidermal cells defines them as a major site of precursor biosynthesis in the vindoline pathway in <italic>Catharanthus roseus</italic></article-title><source>Plant J.</source><year>2005</year><volume>44</volume><fpage>581</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1111/j.1365-313X.2005.02557.x</pub-id><?supplied-pmid 16262708?><pub-id pub-id-type="pmid">16262708</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y-P</given-names></name><etal/></person-group><article-title>Melodinines M-U, cytotoxic alkaloids from <italic>Melodinus suaveolens</italic>. J</article-title><source>Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1021/np2009169</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler</surname><given-names>FE</given-names></name><name><surname>Bennett</surname><given-names>GB</given-names></name></person-group><article-title>Total synthesis of (+&#8722;)-tabersonine</article-title><source>J. Am. Chem. Soc.</source><year>1971</year><volume>93</volume><fpage>5930</fpage><lpage>5931</lpage><pub-id pub-id-type="doi">10.1021/ja00751a076</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozmin</surname><given-names>SA</given-names></name><name><surname>Iwama</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Rawal</surname><given-names>VH</given-names></name></person-group><article-title>An efficient approach to <italic>Aspidosperma</italic> alkaloids via [4&#8201;+&#8201;2] cycloadditions of aminosiloxydienes: Stereocontrolled total synthesis of (&#177;)-tabersonine. Gram-scale catalytic asymmetric syntheses of (+)-tabersonine and (+)-16-methoxytabersonine. Asymmetric Syntheses of (+)-Aspidospermidine and (&#8722;)-Quebrachamine</article-title><source>J. Am. Chem. Soc.</source><year>2002</year><volume>124</volume><fpage>4628</fpage><lpage>4641</lpage><pub-id pub-id-type="doi">10.1021/ja017863s</pub-id><?supplied-pmid 11971711?><pub-id pub-id-type="pmid">11971711</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J-Y</given-names></name><name><surname>Suhl</surname><given-names>C-H</given-names></name><name><surname>Lee</surname><given-names>J-H</given-names></name><name><surname>Cho</surname><given-names>C-G</given-names></name></person-group><article-title>Directed Fischer Indolization as an Approach to the Total Syntheses of (+)-Aspidospermidine and (&#8722;)-Tabersonine</article-title><source>Org. Lett.</source><year>2017</year><volume>19</volume><fpage>6168</fpage><lpage>6171</lpage><pub-id pub-id-type="doi">10.1021/acs.orglett.7b03078</pub-id><?supplied-pmid 29120191?><pub-id pub-id-type="pmid">29120191</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Gagne, R. A. <italic>The Isolation of Tabersonine and the Synthesis of Vincamine</italic>, <ext-link ext-link-type="uri" xlink:href="https://idl-bnc-idrc.dspacedirect.org/handle/10625/6075">https://idl-bnc-idrc.dspacedirect.org/handle/10625/6075</ext-link> (1991).</mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Levy, J. <italic>US Patent</italic> US3892755 A (1975).</mixed-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name></person-group><article-title>Synthesis of C-10 tabersonine analogues by palladium-catalyzed cross-coupling reactions</article-title><source>Synth.</source><year>2014</year><volume>46</volume><fpage>3199</fpage><lpage>3206</lpage><pub-id pub-id-type="doi">10.1055/s-0034-1378659</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><etal/></person-group><article-title>Structure&#8211;Activity Relationship (SAR) Optimization of 6-(Indol-2-yl)pyridine-3-sulfonamides: Identification of Potent, Selective, and Orally Bioavailable Small Molecules Targeting Hepatitis C (HCV) NS4B</article-title><source>J. Med. Chem.</source><year>2014</year><volume>57</volume><fpage>2121</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.1021/jm401621g</pub-id><?supplied-pmid 24266880?><pub-id pub-id-type="pmid">24266880</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Falck</surname><given-names>JR</given-names></name></person-group><article-title>Mild and rapid hydroxylation of aryl/heteroaryl boronic acids and boronate esters with N-oxides</article-title><source>Org. Lett.</source><year>2012</year><volume>14</volume><fpage>3494</fpage><lpage>3497</lpage><pub-id pub-id-type="doi">10.1021/ol301463c</pub-id><?supplied-pmid 22731862?><pub-id pub-id-type="pmid">22731862</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoh</surname><given-names>H</given-names></name><name><surname>Duncan</surname><given-names>KK</given-names></name><name><surname>Robertson</surname><given-names>WM</given-names></name><name><surname>Boger</surname><given-names>DL</given-names></name></person-group><article-title>10&#8242;-fluorovinblastine and 10&#8242;-fluorovincristine: Synthesis of a key series of modified vinca alkaloids</article-title><source>ACS Med. Chem. Lett.</source><year>2011</year><volume>2</volume><fpage>948</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1021/ml200236a</pub-id><?supplied-pmid 22247789?><pub-id pub-id-type="pmid">22247789</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofsl&#248;kken</surname><given-names>NU</given-names></name><etal/></person-group><article-title>Convenient Method for the ortho-Formylation of Phenols</article-title><source>Acta Chemica Scandinavica.</source><year>1999</year><volume>53</volume><fpage>258</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.3891/acta.chem.scand.53-0258</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzm&#225;n.</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Baeyer-Villiger Oxidation of &#946;-Aryl Substituted Unsaturated Carbonyl Compounds with Hydrogen Peroxide and Catalytic Selenium Dioxide</article-title><source>Synth. Commun.</source><year>1995</year><volume>25</volume><fpage>2121</fpage><lpage>2133</lpage><pub-id pub-id-type="doi">10.1080/00397919508015893</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hengartner</surname><given-names>MO</given-names></name></person-group><article-title>The biochemistry of apoptosis</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>770</fpage><lpage>776</lpage><pub-id pub-id-type="doi">10.1038/35037710</pub-id><?supplied-pmid 11048727?><pub-id pub-id-type="pmid">11048727</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#225;lez-Cid</surname><given-names>M</given-names></name><name><surname>Cuello</surname><given-names>MT</given-names></name><name><surname>Larripa</surname><given-names>I</given-names></name></person-group><article-title>Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes</article-title><source>Mutagenesis</source><year>1999</year><volume>14</volume><fpage>63</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1093/mutage/14.1.63</pub-id><?supplied-pmid 10474823?><pub-id pub-id-type="pmid">10474823</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prota</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Structural basis of tubulin tyrosination by tubulin tyrosine ligase</article-title><source>J. Cell Biol.</source><year>2013</year><volume>200</volume><fpage>259</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1083/jcb.201211017</pub-id><?supplied-pmid 23358242?><pub-id pub-id-type="pmid">23358242</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prota</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>587</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1126/science.1230582</pub-id><?supplied-pmid 23287720?><pub-id pub-id-type="pmid">23287720</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouhard</surname><given-names>GJ</given-names></name><name><surname>Rice</surname><given-names>LM</given-names></name></person-group><article-title>The contribution of&#8239; <italic>&#945;&#946;</italic>-tubulin curvature to microtubule dynamic</article-title><source>s. J. Cell Biol.</source><year>2014</year><volume>207</volume><fpage>323</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1083/jcb.201407095</pub-id><?supplied-pmid 25385183?><pub-id pub-id-type="pmid">25385183</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prota</surname><given-names>AE</given-names></name><etal/></person-group><article-title>The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization</article-title><source>J. Mol. Biol.</source><year>2014</year><volume>426</volume><fpage>1848</fpage><lpage>1860</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2014.02.005</pub-id><?supplied-pmid 24530796?><pub-id pub-id-type="pmid">24530796</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravelli</surname><given-names>RBG</given-names></name><etal/></person-group><article-title>Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain</article-title><source>Nature</source><year>2004</year><volume>428</volume><fpage>198</fpage><pub-id pub-id-type="doi">10.1038/nature02393</pub-id><?supplied-pmid 15014504?><pub-id pub-id-type="pmid">15014504</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorleans</surname><given-names>A</given-names></name><etal/></person-group><article-title>Variations in the colchicine-binding domain provide insight into the structural switch of tubulin</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2009</year><volume>106</volume><fpage>13775</fpage><lpage>13779</lpage><pub-id pub-id-type="doi">10.1073/pnas.0904223106</pub-id><?supplied-pmid 19666559?><pub-id pub-id-type="pmid">19666559</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaspari</surname><given-names>R</given-names></name><name><surname>Prota</surname><given-names>AE</given-names></name><name><surname>Bargsten</surname><given-names>K</given-names></name><name><surname>Cavalli</surname><given-names>A</given-names></name><name><surname>Steinmetz</surname><given-names>MO</given-names></name></person-group><article-title>Structural basis of cis- and trans-combretastatin binding to tubulin</article-title><source>Chem.</source><year>2017</year><volume>2</volume><fpage>102</fpage><lpage>113.54</lpage><pub-id pub-id-type="doi">10.1016/j.chempr.2016.12.005</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>DD</given-names></name></person-group><article-title>An overview of tubulin inhibitors that interact with the colchicine binding site</article-title><source>Pharm. Res.</source><year>2012</year><volume>29</volume><fpage>2943</fpage><lpage>2971</lpage><pub-id pub-id-type="doi">10.1007/s11095-012-0828-z</pub-id><?supplied-pmid 22814904?><pub-id pub-id-type="pmid">22814904</pub-id></element-citation></ref></ref-list></back></article>